Paper36967770
The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells.
Wolf L and 2 others. Front Endocrinol (Lausanne), 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells. Papers, record 36967770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36967770
- Cell line
- MDCK79 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Animals | |
| Mice | |
| Canagliflozin | |
| Hypoglycemic Agents | |
| Kidney | |
| Hormones | |
| Benzhydryl Compounds | |
| Glucosides |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27292223 | In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling. | Kidney Int | 2016 | https://conductscience.org/library/papers/27292223 | PubMed |
| 2 | 32860942 | SGLT2 inhibitors for prevention of cardiorenal events in people with type 2 diabetes without cardiorenal disease: A meta-analysis of large randomized trials and cohort studies. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32860942 | PubMed |
| 3 | 25527370 | Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study. | Eur J Epidemiol | 2015 | https://conductscience.org/library/papers/25527370 | PubMed |
| 4 | 32996085 | SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes. | Diabetes Ther | 2020 | https://conductscience.org/library/papers/32996085 | PubMed |
| 5 | 28153033 | Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28153033 | PubMed |
| 6 | 31001673 | Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease. | Diabetologia | 2019 | https://conductscience.org/library/papers/31001673 | PubMed |
| 7 | 25695404 | Molecular basis of Klotho: from gene to function in aging. | Endocr Rev | 2015 | https://conductscience.org/library/papers/25695404 | PubMed |
| 8 | 27941935 | Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. | Nat Rev Nephrol | 2017 | https://conductscience.org/library/papers/27941935 | PubMed |
| 9 | 16436465 | Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. | FASEB J | 2006 | https://conductscience.org/library/papers/16436465 | PubMed |
| 10 | 23563279 | Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data. | Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23563279 | PubMed |
| 11 | 6178742 | The MDCK epithelial cell line expresses a cell surface antigen of the kidney distal tubule. | J Cell Biol | 1982 | https://conductscience.org/library/papers/6178742 | PubMed |
| 12 | 29250031 | New Insights into the Mechanism of Action of Soluble Klotho. | Front Endocrinol (Lausanne) | 2017 | https://conductscience.org/library/papers/29250031 | PubMed |
| 13 | 33637203 | Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. | Kidney Int | 2021 | https://conductscience.org/library/papers/33637203 | PubMed |
| 14 | 36148061 | Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36148061 | PubMed |
| 15 | 22878961 | Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. | J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22878961 | PubMed |
| 16 | 35154011 | The Urinary Glucose Excretion by Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/35154011 | PubMed |
| 17 | 32319182 | Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32319182 | PubMed |
| 18 | 35064106 | A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling. | Nat Commun | 2022 | https://conductscience.org/library/papers/35064106 | PubMed |
| 19 | 31862149 | Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study. | Lancet Diabetes Endocrinol | 2020 | https://conductscience.org/library/papers/31862149 | PubMed |
| 20 | 30519189 | Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients. | Front Physiol | 2018 | https://conductscience.org/library/papers/30519189 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511482 | Global Adam17 Deficiency Preserves Renal Function and Modulates Integrated Pathogenic Responses in Experimental Diabetic Kidney Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511482 | PubMed |
| 41596241 | Chronic Kidney Disease in Metabolic Disease: Regulation of SGLT2 and Transcriptomic-Epigenetic Effects of Its Pharmacological Inhibition. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596241 | PubMed |
| 41316811 | Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome-A case report. | J Diabetes Investig | 2026 | https://conductscience.org/library/papers/41316811 | PubMed |
| 41010553 | Beyond the Cardio-Renal-Metabolic Axis: Emerging Therapeutic Targets and Novel Mechanisms of Action of Flozins. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010553 | PubMed |
| 39409086 | SGLT2 Inhibitors and the Risk of Contrast-Associated Nephropathy Following Angiographic Intervention: Contradictory Concepts and Clinical Outcomes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39409086 | PubMed |
| 39200352 | Insulin Resistance, a Risk Factor for Alzheimer's Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200352 | PubMed |
| 38454800 | SGLT2i improves kidney senescence by down-regulating the expression of LTBP2 in SAMP8 mice. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38454800 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADAM10 | 102 | PubTator's text mining | https://conductscience.org/library/genes/102 | NCBI Gene |
| ADAM17 | 6868 | PubTator's text mining | https://conductscience.org/library/genes/6868 | NCBI Gene |
| FGF23 | 8074 | PubTator's text mining | https://conductscience.org/library/genes/8074 | NCBI Gene |
| KL | 9365 | PubTator's text mining | https://conductscience.org/library/genes/9365 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
| SLC5A1 | 6523 | PubTator's text mining | https://conductscience.org/library/genes/6523 | NCBI Gene |
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
| TBP | 6908 | PubTator's text mining | https://conductscience.org/library/genes/6908 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36967770
GET https://conductscience.org/api/papers/v1/36967770/references?page=2